Four representatives of the pacemaker industry served as panel members for a presentation and open discussion of the present state of industrial development of devices. Each panel member made a brief presentation describing his or her own company's approach to antitachycardia pacing. The panelists had been encouraged to provide as much detail about novel features as proprietary considerations would allow, as well as device limitatioris and major problems. Summaries of the initial presentations appear below, followed by the discussions which ensued.Dr. Martin: Traditionally, tachycardias have been classified into two basic categories: those resulting from abnormal automaticity, and tbose produced by a rapidly circulating impulse in an anatomically or functionally determined reentrant pathway. Reentrant tachycardias are readily initiated and terminated by pacing. Termination depends upon the delivery, of a pacing pulse of sufficient prematurity to "coUide" with the tachycardia wavefront, thereby interrupting the circus pathway. Success in termination depends on several factors, including the type and nature of the tachycardia, the proximity of the pacing electrode to the tachycardia circuit, the reliable detection of the tachycardia, and the delivery of impulses at the proper time.Accepted forms of pacing for tachycardias include overdrive pacing, underdrive pacing, single or double extrastimuli, train pacing, and simultaneous pacing at two (or more] sites.The mechanism involved in tachycardia overdrive pacing (often referred to as burst pacing) requires pacing at a rate in excess of the tachycardia with 1:1 capture for a few impulses, followed by abrupt cessation of pacing.A specific example of an automatic burst pacemaker is the CyberTach* 60. This pacemaker was developed approximately 5i years ago and has been in clinical use for the last 4 years. Prior to the time of its introduction, some success had been achieved with patient-activated devices.The CyberTach 60 circumvents the problems associated with patient-activated systems. The device, after automatically detecting the tachycardia, delivers a rapid burst of pulses at a programmable rate and duration. Tachycardia detection is based upon the presence of 7 consecutive intrinsic intervals with a cycle length shorter than the programmable tachycardia criterion.In addition to its burst capabilities, the device also operates as a conventional demand pacemaker.To date, there have been 172 clinical implantations of the CyberTach 60; 114 atrial applications and 58 ventricular applications. Clinical evaluation of this system has been limited to a relatively small number of institutions which have the capability of performing the thorough electrophysiologic examination required prior to implantation. Through the use of intracardiac recording and programmed electrical stimulation, the mechanism of an arrhythmia is identified and localized. The tachycardia is then initiated and terminated with programmed stimulation. These initial studies are of paramount importance in ...